Mapping the road forward in Alzheimer's disease

Science Translational Medicine

Volumn 3, Issue 114, 2011, Pages

  Holtzman, David M ^a   Goate, Alison ^a,b   Kelly, Jeffrey ^c   Sperling, Reisa ^d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E; APOLIPOPROTEIN E4; FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; AMYLOID PLAQUE; BRAIN SIZE; CYTOLOGY; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; ENVIRONMENTAL FACTOR; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE METABOLISM; GLYCOLYSIS; HEREDITY; HOMOZYGOSITY; HUMAN; HUNTINGTON CHOREA; ISOTOPE LABELING; LIPID METABOLISM; MULTIPLE SCLEROSIS; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROFIBRILLARY TANGLE; NONHUMAN; ONSET AGE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PHENOTYPE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN FOLDING; REVIEW; RISK FACTOR; SYMPTOMATOLOGY;

ALZHEIMER DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS;

EID: 84255172344     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003529     Document Type: Review

References (21)

1. D. M. Holtzman, J. C. Morris, A. M. Goate, Alzheimer's disease: The challenge of the second century. Sci. Transl. Med. 3, 77sr1 (2011).
2. L. Bertram, C. M. Lill, R. E. Tanzi, The genetics of Alzheimer disease: Back to the future. Neuron 68, 270-281 (2010).
3. J. Kim, J. M. Basak, D. M. Holtzman, The role of apolipoprotein E in Alzheimer's disease. Neuron 63, 287-303 (2009).
4. L. Bertram, C. Lange, K. Mullin, M. Parkinson, M. Hsiao, M. F. Hogan, B. M. Schjeide, B. Hooli, J. Divito, I. Ionita, H. Jiang, N. Laird, T. Moscarillo, K. L. Ohlsen, K. Elliott, X. Wang, D. Hu-Lince, M. Ryder, A. Murphy, S. L. Wagner, D. Blacker, K. D. Becker, R. E. Tanzi, Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am. J. Hum. Genet. 83, 623-632 (2008).
5. A. C. Naj, G. Jun, G. W. Beecham, L. S. Wang, B. N. Vardarajan, J. Buros, P. J. Gallins, J. D. Buxbaum, G. P. Jarvik, P. K. Crane, E. B. Larson, T. D. Bird, B. F. Boeve, N. R. Graff-Radford, P. L. De Jager, D. Evans, J. A. Schneider, M. M. Carrasquillo, N. Ertekin-Taner, S. G. Younkin, C. Cruchaga, J. S. K. Kauwe, P. Nowotny, P. Kramer, J. Hardy, M. J. Huentelman, A. J. Myers, M. M. Barmada, F. Y. Demirci, C. T. Baldwin, R. C. Green, E. Rogaeva, P. St George-Hyslop, S. E. Arnold, R. Barber, T. Beach, E. H. Bigio, J. D. Bowen, A. Boxer, J. R. Burke, N. J. Cairns, C. S. Carlson, R. M. Carney, S. L. Carroll, H. C. Chui, D. G. Clark, J. Corneveaux, C. W. Cotman, J. L. Cummings, C. DeCarli, S. T. DeKosky, R. Diaz-Arrastia, M. Dick, D. W. Dickson, W. G. Ellis, K. M. Faber, K. B. Fallon, M. R. Farlow, S. Ferris, M. P. Frosch, D. R. Galasko, M. Ganguli, M. Gearing, D. H. Geschwind, B. Ghetti, J. R. Gilbert, S. Gilman, B. Giordani, J. D. Glass, J. H. Growdon, R. L. Hamilton, L. E. Harrell, E. Head, L. S. Honig, C. M. Hulette, B. T. Hyman, G. A. Jicha, L.-W. Jin, N. Johnson, J. Karlawish, A. Karydas, J. A. Kaye, R. Kim, E. H. Koo, N. W. Kowall, J. J. Lah, A. I. Levey, A. P. Lieberman, O. L. Lopez, W. J. Mack, D. C. Marson, F. Martiniuk, D. C. Mash, E. Masliah, W. C. McCormick, S. M. McCurry, A. N. McDavid, A. C. McKee, M. Mesulam, B. L. Miller, C. A. Miller, J. W. Miller, J. E. Parisi, D. P. Perl, E. Peskind, R. C. Petersen, W. W. Poon, J. F. Quinn, R. A. Rajbhandary, M. Raskind, B. Reisberg, J. M. Ringman, E. D. Roberson, R. N. Rosenberg, M. Sano, L. S. Schneider, W. Seeley, M. L. Shelanski, M. A. Slifer, C. D. Smith, J. A. Sonnen, S. Spina, R. A. Stern, R. E. Tanzi, J. Q. Trojanowski, J. C. Troncoso, V. M. Van Deerlin, H. V. Vinters, J. P. Vonsattel, S. Weintraub, K. A. Welsh-Bohmer, J. Williamson, R. L. Woltjer, L. B. Cantwell, B. A. Dombroski, D. Beekly, K. L. Lunetta, E. R. Martin, M. I. Kamboh, A. J. Saykin, E. M. Reiman, D. A. Bennett, J. C. Morris, T. J. Montine, A. M. Goate, D. Blacker, D. W. Tsuang, H. Hakonarson, W. A. Kukull, T. M. Foroud, J. L. Haines, R. Mayeux, M. A. Pericak-Vance, L. A. Farrer, G. D. Schellenberg, Common variants at MS4A4/ MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43, 436-441 (2011).
6. P. Hollingworth, D. Harold, R. Sims, A. Gerrish, J. C. Lambert, M. M. Carrasquillo, R. Abraham, M. L. Hamshere, J. S. Pahwa, V. Moskvina, K. Dowzell, N. Jones, A. Stretton, C. Thomas, A. Richards, D. Ivanov, C. Widdowson, J. Chapman, S. Lovestone, J. Powell, P. Proitsi, M. K. Lupton, C. Brayne, D. C. Rubinsztein, M. Gill, B. Lawlor, A. Lynch, K. S. Brown, P. A. Passmore, D. Craig, B. McGuinness, S. Todd, C. Holmes, D. Mann, A. D. Smith, H. Beaumont, D. Warden, G. Wilcock, S. Love, P. G. Kehoe, N. M. Hooper, E. R. Vardy, J. Hardy, S. Mead, N. C. Fox, M. Rossor, J. Collinge, W. Maier, F. Jessen, E. Rüther, B. Schürmann, R. Heun, H. Kölsch, H. van den Bussche, I. Heuser, J. Kornhuber, J. Wiltfang, M. Dichgans, L. Frölich, H. Hampel, J. Gallacher, M. Hüll, D. Rujescu, I. Giegling, A. M. Goate, J. S. Kauwe, C. Cruchaga, P. Nowotny, J. C. Morris, K. Mayo, K. Sleegers, K. Bettens, S. Engelborghs, P. P. De Deyn, C. Van Broeckhoven, G. Livingston, N. J. Bass, H. Gurling, A. McQuillin, R. Gwilliam, P. Deloukas, A. Al-Chalabi, C. E. Shaw, M. Tsolaki, A. B. Singleton, R. Guerreiro, T. W. Mühleisen, M. M. Nöthen, S. Moebus, K. H. Jöckel, N. Klopp, H. E. Wichmann, V. S. Pankratz, S. B. Sando, J. O. Aasly, M. Barcikowska, Z. K. Wszolek, D. W. Dickson, N. R. Graff -Radford, R. C. Petersen, C. M. van Duijn, M. M. Breteler, M. A. Ikram, A. L. DeStefano, A. L. Fitzpatrick, O. Lopez, L. J. Launer, S. Seshadri, C. Berr, D. Campion, J. Epelbaum, J. F. Dartigues, C. Tzourio, A. Alpérovitch, M. Lathrop, T. M. Feulner, P. Friedrich, C. Riehle, M. Krawczak, S. Schreiber, M. Mayhaus, S. Nicolhaus, S. Wagenpfeil, S. Steinberg, H. Stefansson, K. Stefansson, J. Snaedal, S. Björnsson, P. V. Jonsson, V. Chouraki, B. Genier-Boley, M. Hiltunen, H. Soininen, O. Combarros, D. Zelenika, M. Delepine, M. J. Bullido, F. Pasquier, I. Mateo, A. Frank-Garcia, E. Porcellini, O. Hanon, E. Coto, V. Alvarez, P. Bosco, G. Siciliano, M. Mancuso, F. Panza, V. Solfrizzi, B. Nacmias, S. Sorbi, P. Bossù, P. Piccardi, B. Arosio, G. Annoni, D. Seripa, A. Pilotto, E. Scarpini, D. Galimberti, A. Brice, D. Hannequin, F. Licastro, L. Jones, P. A. Holmans, T. Jonsson, M. Riemenschneider, K. Morgan, S. G. Younkin, M. J. Owen, M. O'Donovan, P. Amouyel, J. Williams; Alzheimer's Disease Neuroimaging Initiative; CHARGE consortium; EADI1 consortium, Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429-435 (2011).
7. R. Tarawneh, G. D'Angelo, E. Macy, C. Xiong, D. Carter, N. J. Cairns, A. M. Fagan, D. Head, M. A. Mintun, J. H. Ladenson, J. M. Lee, J. C. Morris, D. M. Holtzman, Visinin-like protein-1: Diagnostic and prognostic biomarker in Alzheimer disease. Ann. Neurol. 70, 274-285 (2011).
8. R. A. Sperling, C. R. Jack Jr., P. S. Aisen, Testing the right target and right drug at the right stage. Sci. Transl. Med. 3, 111cm33 (2011).
9. R. A. Sperling, P. S. Aisen, L. A. Beckett, D. A. Bennett, S. Craft, A. M. Fagan, T. Iwatsubo, C. R. Jack Jr., J. Kaye, T. J. Montine, D. C. Park, E. M. Reiman, C. C. Rowe, E. Siemers, Y. Stern, K. Yaff e, M. C. Carrillo, B. Thies, M. Morrison- Bogorad, M. V. Wagster, C. H. Phelps, Toward defi ning the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 280-292 (2011).
10. C. R. Jack Jr., D. S. Knopman, W. J. Jagust, L. M. Shaw, P. S. Aisen, M. W. Weiner, R. C. Petersen, J. Q. Trojanowski, Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 9, 119-128 (2010).
11. R. J. Perrin, A. M. Fagan, D. M. Holtzman, Multimodal techniques for diagnosis and prognosis of Alzheimer's disease. Nature 461, 916-922 (2009).
12. M. S. Albert, S. T. DeKosky, D. Dickson, B. Dubois, H. H. Feldman, N. C. Fox, A. Gamst, D. M. Holtzman, W. J. Jagust, R. C. Petersen, P. J. Snyder, M. C. Carrillo, B. Thies, C. H. Phelps, The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 7, 270-279 (2011).
13. J. C. Breitner, L. D. Baker, T. J. Montine, C. L. Meinert, C. G. Lyketsos, K. H. Ashe, J. Brandt, S. Craft, D. E. Evans, R. C. Green, M. S. Ismail, B. K. Martin, M. J. Mullan, M. Sabbagh, P. N. Tariot; ADAPT Research Group, Extended results of the Alzheimer's disease anti-infl ammatory prevention trial. Alzheimers Dement. 7, 402-411 (2011).
14. K. G. Mawuenyega, W. Sigurdson, V. Ovod, L. Munsell, T. Kasten, J. C. Morris, K. E. Yarasheski, R. J. Bateman, Decreased clearance of CNS beta-amyloid in Alzheimer's disease. Science 330, 1774 (2010).
15. S. Oddo, A. Caccamo, J. D. Shepherd, M. P. Murphy, T. E. Golde, R. Kayed, R. Metherate, M. P. Mattson, Y. Akbari, F. M. LaFerla, Triple-transgenic model of Alzheimer's disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421 (2003).
16. D. M. Skovronsky, V. M. Lee, J. Q. Trojanowski, Neurodegenerative diseases: New concepts of pathogenesis and their therapeutic implications. Annu. Rev. Pathol. 1, 151-170 (2006).
17. S. L. Lindquist, J. W. Kelly, Chemical and biological approaches for adapting proteostasis to ameliorate protein misfolding and aggregation diseases-progress and prognosis. Cold Spring Harb. Perspect. Biol. 3, a004507 (2011).
18. B. Frost, M. I. Diamond, Prion-like mechanisms in neurodegenerative diseases. Nat. Rev. Neurosci. 11, 155-159 (2010).
19. J. Hardy, D. J. Selkoe, The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356 (2002).
20. S. H. Choi, K. Veeraraghavalu, O. Lazarov, S. Marler, R. M. Ransohoff, J. M. Ramirez, S. S. Sisodia, Non-cellautonomous eff ects of presenilin 1 variants on enrichment- mediated hippocampal progenitor cell proliferation and diff erentiation. Neuron 59, 568-580 (2008).
21. A. G. Vlassenko, S. N. Vaishnavi, L. Couture, D. Sacco, B. J. Shannon, R. H. Mach, J. C. Morris, M. E. Raichle, M. A. Mintun, Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc. Natl. Acad. Sci. U.S.A. 107, 17763-17767 (2010).